Showing results (341-350 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|October 1, 1994
Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cellsS Huang, R K Singh, K Xie, et al.Cancer Immunology, Immunotherapy : CII|October 1, 1994
Cytokine-mediated antitumor effect of bacillus Calmette-Guérin on tumor cells in vitroH Kurisu, H Matsuyama, Y Ohmoto, et al.Cancer Immunology, Immunotherapy : CII|October 1, 1994
Adjuvant immunotherapy with intrapleural Streptococcus pyogenes (OK-432) in lung cancer patients after resectionY C Lee, S P Luh, R M Wu, et al.Cancer Immunology, Immunotherapy : CII|June 1, 1993
Eradication of metastatic tumour cells from lymph nodes by local administration of anti-CD3 antibodyY Dohi, S Sunada, M Aoki, et al.Cancer Immunology, Immunotherapy : CII|June 1, 1994
A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-alpha 2a in patients with advanced malignant melanomaI G Ron, Y Mordish, A Eisenthal, et al.Cancer Immunology, Immunotherapy : CII|June 1, 1994
Interferon beta enhances the natural killer activity of patients with bladder carcinomaL Moltó, J Carballido, L Manzano, et al.Cancer Immunology, Immunotherapy : CII|June 1, 1997
Priming of the antitumor response promotes efficacy of interleukin-2 therapyL A Everse, M R Bernsen, H F Dullens, et al.Cancer Immunology, Immunotherapy : CII|May 1, 1997
Toxicological and immunological evaluation of the MHC-non-restricted cytotoxic T cell line TALL-104A Cesano, S Visonneau, J H Wolfe, et al.Cancer Immunology, Immunotherapy : CII|November 19, 2009
Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccinationMohamed Labib Salem, David J ColeCancer Immunology, Immunotherapy : CII|January 1, 1991
A murine plasmacytoma MOPC 104E resistant to cyclophosphamide is resistant to immunotherapyK Satoh, N Kan, T Okino, et al.Pageof 650